Virtual Reality Learning Experience: Prevention and Control of Human Papillomavirus (HPV)

REGISTER NOW!
Already Registered?
SIGN IN

WEBCAST DATE

Wednesday, October 10, 2018

7:30 AM Eastern    6:30 AM Central    5:30 AM Mountain    4:30 AM Pacific

PROGRAM FEATURES

• VIRTUAL REALITY SETS provided to all attendees for viewing this presentation only
• Case-based learning environment

FACULTY

Warner Huh, MD
Obstetrics and Gynecology Professor
Center for AIDS Research
Comprehensive Cancer Center
University of Alabama at Birmingham Hospital
Birmingham, AL

Maura L. Gillison, MD, PhD
Professor, Department of Thoracic/Head and Neck Medical Oncology
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

AGENDA

I. Introduction

II. HPV structure and function
  a. Low risk vs high risk
  b. Epithelial infection
  c. Importance of virus-like particles (VLP)
  d. Link between HPV and cancer types
    i. Anal, penile, vulvar, vaginal, head/neck
  e. HPV in males

III. HPV vaccine
  a. History of vaccines (2-, 4-, and 9-valent)
  b. Safety and efficacy
  c. Activity in vitro

IV. HPV vaccination and the adult patient (>19 years)
  a. Current guideline recommendations
    i. Age 19–26 years; special populations
  b. Vaccine trends among adults
    i. Provider- and patient-specific factors
  c. Clinical decision making

V. Impact of HPV
  a. Global impact
  b. Guideline recommendations
  c. Case study(s)

VI. Conclusions and Q/A

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

• Discuss the types of cancer, other than cervical cancer, that have strong associations with HPV DNA, and explain the characteristics and factors exposing these associations
• Describe the underlying mechanisms and discuss clinical data looking at the safety and efficacy of HPV vaccination
• Review available data regarding HPV vaccination, highlighting adult patients and current guidelines for this patient population
• Improve provider knowledge of current HPV vaccine schedule recommendations, and discuss optimal methods of communication for patients inquiring about HPV vaccine

TARGET AUDIENCE

This educational activity is designed to meet the educational needs of primary care doctors, nurses, and other healthcare professionals involved in the care of patients aged 19 or older who are eligible for HPV vaccination.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 1.5 AMA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Purpose:
This program would be beneficial for nurses involved in the care of patients who are eligible for HPV vaccination.

Credits:
1.5 ANCC Contact Hours

CNE Accreditation Statement:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.5 contact hours of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

This event is not a part of the official AAFP FMX.

Copyright © 2018 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.